Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

CLRO earnings analysis

Filed August 14, 2026 · Our reading of the company's report

The latest report

This 10-Q extract does not provide quarterly revenue, margins, EPS, balance-sheet figures or cash-flow data, so operating performance versus the prior period and prior year cannot be assessed from the filing information…

Read full summary

This 10-Q extract does not provide quarterly revenue, margins, EPS, balance-sheet figures or cash-flow data, so operating performance versus the prior period and prior year cannot be assessed from the filing information supplied. The company states that continuing activities are not expected to generate material revenue sufficient to fund ongoing operating costs, leaving reliance on the merger, financing or additional capital. Key negatives are the $2,500,000 Nasdaq equity deficiency, the July 8, 2026 change-of-control listing requirement, potential failure of the merger within 180 days, and substantial dilution from 12,500,000 consideration shares plus up to 855,000 advisor shares.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

34% Gross margin Operating margin Mar 2023 Aug 2025

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Mar 2023 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

What stood out

  • Disclosure controls remained effective

    Management concluded that disclosure controls and procedures were effective as of June 30, 2026, and reported no changes during the quarter that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.

  • Nasdaq compliance plan submitted

    The company submitted a Nasdaq compliance plan on May 22, 2026 after receiving an April 7, 2026 notice regarding the $2,500,000 stockholders’ equity requirement under Nasdaq Rule 5550(b)(1).

  • Merger transaction remains active

    The proposed merger includes 12,500,000 consideration shares and up to 855,000 advisor shares, representing approximately 82% of common stock on a pro forma basis before the financing.

What to watch

  • Nasdaq delisting risk increased

    Nasdaq notified the company on April 7, 2026 that it was not compliant with the $2,500,000 minimum stockholders’ equity requirement. Separately, on July 8, 2026, Nasdaq determined the merger is a change of control requiring the post-transaction entity to satisfy initial listing requirements, creating a material delisting risk.

  • Merger and financing may fail

    The merger and financing are subject to conditions including stockholder approval, Vivani approval, financing completion, Form S-1 effectiveness and Nasdaq approval. The merger may be terminated if it is not completed within 180 days of signing, and failure to complete it would leave substantial doubt about the company’s ability to continue as a going concern.

  • Limited operations and substantial dilution

    The company states that continuing activities are not expected to generate material revenue sufficient to fund ongoing operating costs. The proposed transaction would issue 12,500,000 consideration shares and up to 855,000 advisor shares, approximately 82% of common stock before financing, while Vivani would hold a majority of voting power.

  • Integration and assumed-liability risk

    The merger would make the company responsible for Cortigent’s legal, financial, regulatory and compliance obligations, including potentially unknown or contingent liabilities. Management identifies integration difficulties such as diversion of attention, systems and personnel integration, and increased expenses that could reduce revenues, earnings and cash flows.

  • Nevada reincorporation changes governance risk

    The company completed reincorporation from Delaware to Nevada on April 22, 2026. Management notes that Nevada law differs from Delaware law regarding stockholder rights, director and officer fiduciary duties, and anti-takeover provisions.

  • Change of control and voting concentration

    Following the merger, existing stockholders would have limited influence because Vivani will designate the CEO, CFO and 4 of 5 directors. Stockholders holding at least 50.1% entered voting support agreements, and the largest stockholder and affiliates holding approximately 61% already approved the share issuance.

Management's outlook

The 10-Q does not provide quantitative revenue or EPS guidance. Management states that continuing activities are not expected to generate material revenue sufficient to fund ongoing operating costs, but no numeric outlook is disclosed.

Earlier filings 4

10-Q · May 15, 2026

ClearOne, Inc.'s Q1 2026 report reflects a significant transition following the asset sale in October 2025, resulting in minimal revenue from continuing operations. The company reported a net loss of $487,000, a…

10-K · March 31, 2026

ClearOne completed an Asset Sale on October 24, 2025 for gross cash consideration of $3.0 million and has transitioned to a transitional posture where it no longer manufactures or sells products and continuing…

10-Q · November 14, 2025

ClearOne, Inc. reported a challenging third quarter for the period ending September 30, 2025, with significant losses both on the income statement and in cash flows, as the company continues its restructuring amid asset…

10-Q · August 14, 2025

ClearOne, Inc. reported a decline in total revenues to $1.92 million for Q2 2025, down from $2.30 million in Q2 2024, contributing to a deepening net loss of $4.57 million vs. a loss of $2.82 million last year. The…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.